Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Alzheimer

Biogen Announces Pursual of FDA Approval for Aducanumab

Biogen and its Japanese partner Eisai announced Oct. 22nd an unexpected reversal—pharmaceutical giant Biogen said it will pursue US Food […]

Biogen Announces Pursual of FDA Approval for Aducanumab
1 year ago
Share

AbbVie Stops an Anti-Tau Study and Biogen’s Studies May be in for Trouble

AbbVie terminated a clinical trial of its intravenously administered antibody, designed to slow the progression of Progressive Supranuclear Palsy (PSP), […]

AbbVie Stops an Anti-Tau Study and Biogen’s Studies May be in for Trouble
2 years ago
Share

UC Davis Joins U.S. POINTER Study: Does Healthy Lifestyle Reduce Alzheimer’s Risk?

The Alzheimer’s Association gave $6 million to the University of California, Davis, to fund its participation in the U.S. POINTER […]

healthy eating concept
2 years ago
Share

Amgen and Novartis Drop Alzheimer’s Prevention Studies

After a review of the clinical data, sponsors Amgen and Novartis have concluded that the potential benefit for participants in […]

Alzheimer's
2 years ago
Share

Kerwin Research Center & Memory Care President Inks Deal with CTD Holding

Kerwin Research Center and Memory Care focuses on the care, evaluation and treatment of memory loss and dementia due to […]

Kerwin Research Center & Memory Care
2 years ago
Share

Washington University Study Shows Alzheimer’s Progression May Hinge on Newfound Amyloid & Tau Link

Weak microglia may constitute a link between two hallmarks of Alzheimer’s disease—clumps of amyloid- β protein and tangles of tau […]

Medical.
2 years ago
Share

Lund University & Skane Hospital Studies Evidence that Blood Tests Detect Alzheimer’s Disease

A Lund University Study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in […]

Head erased by pencil eraser
2 years ago
Share

University of Chicago Researchers Identify Modified Protein that can Prevent Alzheimer’s in Mice

University of Chicago researchers engaged in preclinical research have redeemed amyloid precursor protein (APP), a contributor to Alzheimer’s disease, as […]

Mice Alzheimer
2 years ago
Share

University of South Florida-led Preclinical Study Helps Uncover Possible New Alzheimer’s Disease Therapeutic Target

University of South Florida-Led preclinical study helps uncovered promising therapeutic target for Alzheimer’s disease. Researchers have known that Apolipoprotein E […]

apoE
2 years ago
Share

Atlanta VA & Emory Study the Connection Between High LDL Cholesterol & Early-Onset Alzheimer’s

Janice Wood of PsychCentral reports that new research has uncovered a link between high LDL cholesterol levels and early-onset Alzheimer’s […]

Cardiovascular Disease and CNS
2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.